5-Amino-1MQ
Small-molecule NNMT inhibitorAn experimental NNMT inhibitor studied for metabolic effects in mice.
5A1MQ · 5-amino-1-methylquinolinium
Fact sheet library
Search by name or research interest. Read benefits, risks, personal accounts and clinical findings.
An experimental NNMT inhibitor studied for metabolic effects in mice.
5A1MQ · 5-amino-1-methylquinolinium
A metabolic intermediate studied for aging, mainly in mice.
AKG · 2-oxoglutarate · calcium alpha-ketoglutarate · Ca-AKG
An antioxidant studied for diabetic nerve symptoms, with mixed results across trial durations and endpoints.
ALA · Thioctic acid
A growth-hormone fragment studied for obesity, without an FDA-approved weight-loss use.
AOD9604 · Tyr-hGH 177–191
A botanical extract studied for stress and sleep, with formulation differences and reported liver-safety concerns.
Withania somnifera
A plant alkaloid studied for glucose and lipid changes, with uncertain weight-loss benefits and important interactions.
An experimental peptide with very limited reliable human evidence.
Body Protection Compound 157
A melanocortin-receptor peptide approved for a narrowly defined sexual-desire disorder.
Vyleesi · PT-141
An investigational long-acting amylin analog studied alone and with semaglutide for obesity and type 2 diabetes.
AM833 · long-acting amylin analog
An unapproved growth hormone-releasing hormone analog with limited human data.
CJC-1295 DAC
A supplement with established exercise evidence and less certain cognitive benefits.
creatine monohydrate · methylguanidineacetic acid
An experimental senolytic combination of a cancer medicine and a flavonoid.
D+Q · DQ senolytic combination
A cognition research compound with preclinical HGF/c-Met findings and major human safety gaps.
PNB-0408 · Dihexa acetate
A sleep research peptide with small, inconsistent older human studies.
Delta sleep-inducing peptide · Emideltide
A mitochondria-targeting peptide with an accelerated FDA approval for a narrow Barth syndrome indication.
Forzinity · SS-31 · MTP-131 · Bendavia
An oral macrocyclic peptide approved as Lipfendra to lower LDL cholesterol in specified adult populations.
Enlicitide decanoate · MK-0616 · Lipfendra
An experimental peptide associated with telomere and aging claims, based largely on laboratory evidence.
Epithalon · AEDG
An approved diabetes medicine whose larger Parkinson trial did not confirm earlier findings.
Byetta · Bydureon · exendin-4
A flavonoid with mouse senolytic findings but no proven human longevity benefit.
senolytic flavonoid · dietary fisetin
A copper-binding tripeptide used in cosmetic research, with mostly laboratory and animal wound-healing evidence.
copper tripeptide-1 · copper peptide GHK-Cu
An unapproved ghrelin-receptor agonist that raises growth hormone and appetite without proven muscle-building outcomes.
growth hormone-releasing peptide-2 · pralmorelin
A peptide that releases growth hormone, with limited evidence for meaningful recovery outcomes.
Growth hormone-releasing peptide-6
A tripeptide antioxidant with small human biomarker and skin-pigmentation studies; broad wellness benefits are unproven.
GSH · Reduced glutathione
An amino acid with small sleep studies and broader metabolic research; clinical benefits remain uncertain.
An experimental growth-hormone secretagogue with hormone and sleep effects in small studies.
Examorelin
A mitochondrial-derived peptide studied mainly in cells and animals.
HN · MT-RNR2 peptide · S14G-humanin (experimental analog)
A non-peptide growth-hormone secretagogue with lean-mass findings, glucose effects, and a heart-failure safety signal.
MK-677 · MK-0677 · Ibutamoren mesylate
An unapproved growth hormone secretagogue with limited clinical evidence and FDA-identified concerns.
ipamorelin acetate
Compounds that raise circulating ketones reliably but have not established cognitive or healthy-aging benefit.
BHB · beta-hydroxybutyrate · exogenous ketones · ketone monoester
A reproductive signaling peptide studied in fertility, hormone release, and brain responses.
kisspeptin-54 · kisspeptin-10 · metastin
A short peptide with anti-inflammatory findings in cells and mice, without established human benefits.
Lys-Pro-Val
A tea-derived amino acid studied for stress, attention and sleep, with small and mixed human trials.
Theanine
A minimally absorbed peptide medicine approved for several constipation disorders in defined adult and pediatric populations.
Linzess · guanylate cyclase-C agonist
An established GLP-1 medicine approved for specific diabetes and weight-management uses.
Victoza · Saxenda
A discontinued U.S. GLP-1 product with established diabetes evidence and an encouraging but unconfirmed Parkinson trial.
Adlyxin · Lyxumia · lixisenatide acetate
An unapproved melanocortin peptide associated with tanning and sexual effects, with important safety signals.
Melanotan-2 · MT-II · MT2
A sleep-timing hormone studied for circadian sleep problems; effects depend on the sleep condition and formulation.
A diabetes medicine being studied for aging, without an approved anti-aging use.
Glucophage · metformin hydrochloride
A dye and medicine approved for acquired methemoglobinemia; wellness claims have very different evidence and risks.
Methylthioninium chloride · ProvayBlue
A mitochondrial-derived peptide studied for metabolism and exercise, without a proven human therapy.
MOTS-c peptide · mitochondrial ORF of 12S rRNA type-c
An acetaminophen antidote with separate research into psychiatric symptoms and antioxidant biology.
NAC · Acetylcysteine
A cellular coenzyme with limited clinical evidence for wellness infusions.
nicotinamide adenine dinucleotide · NAD
An NAD+ precursor with small human trials and unresolved real-world clinical value.
NMN · beta-NMN
An NAD+ precursor that reliably changes biomarkers but has not shown a consistent anti-aging or cognitive benefit.
NR · niagen
An oral, non-peptide GLP-1 medicine approved as Foundayo for a defined adult weight-management indication.
Foundayo · LY3502970
A natural peptide hormone with approved obstetric products and unproven intranasal cognitive or social uses.
Pitocin · synthetic oxytocin
An investigational glucagon/GLP-1 dual agonist in mid-stage research for MASH, liver fat, and obesity.
ALT-801
An FDA-approved gut-signaling peptide for chronic idiopathic constipation and IBS with constipation in adults.
Trulance · uroguanylin analog
An FDA-approved amylin analog for selected insulin-treated diabetes patients, with unapproved weight-management research.
Symlin · pramlintide acetate
A flavonoid studied for blood pressure and inflammation; findings do not establish general senolytic or longevity benefits.
A plant polyphenol with mixed human metabolic findings and no established life-extension benefit.
Trans-resveratrol
An investigational triple-receptor agonist in Phase 3 clinical trials.
LY3437943
A hepcidin-mimetic peptide approved as Mimrylo for erythrocytosis in adults with polycythemia vera.
PTG-300 · Mimrylo
An unapproved synthetic heptapeptide studied for anxiety, with a thin and uncertain human evidence base.
Selank acetate · TP-7
A GLP-1 medicine with FDA-approved products for type 2 diabetes and chronic weight management.
Ozempic · Wegovy · Rybelsus
An unapproved neuroactive heptapeptide with old, small human studies and substantial evidence gaps.
Semax heptapeptide · ACTH(4-7)-Pro-Gly-Pro
A growth hormone-releasing hormone analog whose former FDA-approved product was discontinued.
Geref · sermorelin acetate
An MC4-receptor peptide medicine approved for obesity caused by specific rare genetic conditions.
Imcivree · RM-493
An FDA-approved immunosuppressant with serious risks and unproven longevity use in healthy people.
rapamycin · Rapamune
An experimental exercise-mimetic compound studied in cells and mice.
A food-derived polyamine linked to autophagy biology, with a negative phase 2 cognitive primary outcome.
dietary spermidine · polyamine
An investigational glucagon/GLP-1 dual agonist in Phase 3 research for obesity and metabolic liver disease.
BI 456906
A common nutrient-related molecule whose animal longevity story is challenged by human aging data.
2-aminoethanesulfonic acid
An FDA-approved GLP-2 analog that improves intestinal absorption in short bowel syndrome dependent on parenteral support.
Gattex · Revestive · GLP-2 analog
A growth hormone-releasing factor analog approved for a narrow HIV-related indication.
Egrifta SV
An immune-modulating peptide used in some countries but not FDA approved for any U.S. indication.
Tα1 · thymalfasin · Zadaxin
A naturally occurring peptide studied in tissue repair; marketed fragments are not FDA approved.
Tβ4 · TB4 · full-length thymosin beta-4 · TB-500 (fragment marketed online)
A dual GIP/GLP-1 receptor agonist approved for specific metabolic and sleep-apnea uses.
Mounjaro · Zepbound
An FDA-approved synthetic peptide analog for Rett syndrome with modest trial benefits and frequent gastrointestinal adverse effects.
Daybue · NNZ-2566
A mitophagy-related metabolite with human biomarker and muscle-endurance signals but no approved disease use.
UA · pomegranate-derived postbiotic
A C-type natriuretic peptide analog approved to increase growth in children with achondroplasia.
Voxzogo
A cone-snail-inspired peptide medicine approved for severe chronic pain under specialist care.
Prialt · SNX-111